TAM
TCRT icon

Tucker Asset Management’s Alaunos Therapeutics TCRT Stock Holding History

Tucker Asset Management’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$3 – 949
2025
Q4 		$3 Buy
+1
New +$3 ﹤0.01% 1077
2025
Q1 		– Sell
-1
Closed -$2 – 855
2024
Q4 		$2 Hold
1
– – ﹤0.01% 1539
2024
Q3 		$3 Hold
1
– – ﹤0.01% 1452
2024
Q2 		$9 Hold
1
– – ﹤0.01% 1650
2024
Q1 		$24 Hold
1
– – ﹤0.01% 1614
2023
Q4 		$14 Hold
1
– – ﹤0.01% 1447
2023
Q3 		$26 Hold
1
– – ﹤0.01% 1355
2023
Q2 		$102 Hold
1
– – ﹤0.01% 1108
2023
Q1 		$126 Hold
1
– – ﹤0.01% 1116
2022
Q4 		$131 Hold
1
– – ﹤0.01% 775
2022
Q3 		$230 Buy
+1
New +$290 ﹤0.01% 793

Other funds holding TCRT

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Tucker Asset Management's TCRT Position: Q1 2026 in Review

Tucker Asset Management sold out of Alaunos Therapeutics (TCRT) in Q1 2026, closing a stake of 1 share — an estimated $3 sold.

Tucker Asset Management first reported a position in TCRT in Q3 2022 and held it in 11 quarters. The position peaked at $230 in Q3 2022. 29 funds tracked by Wall St. Rank hold TCRT as of Q1 2026.

  • Tucker Asset Management reported no remaining Alaunos Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Tucker Asset Management sold 1 Alaunos Therapeutics share in Q1 2026, an estimated $3.
  • Tucker Asset Management first reported a position in Alaunos Therapeutics in Q3 2022 and held it in 11 quarters.
  • Tucker Asset Management's Alaunos Therapeutics position peaked at $230 in Q3 2022.
  • 29 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2026.

Based on Tucker Asset Management's 13F filing for Q1 2026, filed 27 Aug 2026.